A top-10 list of critical legal issues that biotech start-ups should make an effort to address, even when the capital squeeze is intense.
Judith Toffenetti
Advertisement
Judith Toffenetti is a partner at McDermott Will & Emery
Articles by Judith Toffenetti
Advertisement
Latest Updated Articles
- Top 10 Legal Issues Biotech Start-Ups Must Address
Published: November 1st 2008 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Chiesi–Aliada Partnership Advances BBB-Crossing Technology for Lysosomal Storage Disorders
2
Why Biopharma Developers Should Care About FDA’s New Personalized Therapy Approval Process
3
How Advanced PK/TK Protocols Strengthen Data Integrity
4
BioPharm Weekly News Roundup—Week of Nov. 10, 2025
5
